TREA

90890688 - KARRATIO

Follow

Information

  • Trademark
  • 90890688
  • Serial Number
    90890688
  • Registration Number
    7257160
  • Filing Date
    August 18, 2021
    2 years ago
  • Registration Date
    January 02, 2024
    5 months ago
  • Transaction Date
    January 02, 2024
    5 months ago
  • Status Date
    January 02, 2024
    5 months ago
  • Published for Opposition Date
    October 17, 2023
    8 months ago
  • Location Date
    January 02, 2024
    5 months ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    NOVAKOVIC, MIROSLAV
  • Attorney Docket Number
    T38321LC07
    Attorney Name
    Jong Park
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
KARRATIO
Case File Statements
  • DM0000: The mark consists of a circle design having three sections with colors of purple, orange and red and the word of "Karratio" in red.
  • GS0051: Pharmaceutical preparations for the treatment of cells; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; living cells for medical purposes; living cells for veterinary purposes; cells, namely, chimeric antigen receptor T-cell (CAR-T), for medical purposes; pharmaceutical preparations for activating cellular function; preparations of microorganisms for medical purposes; biological preparations for medical or veterinary purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for health care, namely, pharmaceutical preparations for the treatment of cancer or immune disease; vaccines; colostral, murine, chimeric, humanized, human, monoclonal, and polyclonal antibodies for veterinary purposes; antibodies for medical purposes; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for the treatment of cancers with T cells
  • CC0000: The color(s) purple, orange and red is/are claimed as a feature of the mark.
  • GS0421: Product development in the field of cell therapy; research relating to pharmaceuticals; pharmaceutical drug development services; research and development of pharmaceuticals; research and development of vaccines; cell separation research services; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; biological research; research in the field of gene analysis; genetic research; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
Case File Event Statements
  • 1/2/2024 - 5 months ago
    26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 1/2/2024 - 5 months ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/17/2023 - 8 months ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/17/2023 - 8 months ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/27/2023 - 9 months ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/8/2023 - 9 months ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/29/2023 - 10 months ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/29/2023 - 10 months ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/26/2023 - 10 months ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 4/14/2023 - a year ago
    17 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 3/30/2023 - a year ago
    16 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 3/30/2023 - a year ago
    15 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 3/30/2023 - a year ago
    14 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 9/30/2022 - a year ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 9/30/2022 - a year ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/30/2022 - a year ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 8/30/2022 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/29/2022 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/29/2022 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/26/2022 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/26/2022 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/26/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/19/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/7/2021 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/6/2021 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/21/2021 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP